SUBSCRIBE
SUBSCRIBE

Phase 1

Drug Development
New Weapon Against Alzheimer’s Found
October 19, 2005
 · 
1 min read
Business
ConjuChem
October 19, 2005
 · 
8 min read
Drug Development
New Investigational Vaccine To Prevent Hepatitis C Tested For First Time In Humans
October 19, 2005
 · 
1 min read
Drug Development
Acambis PLC Announces Significant Progress On Its MVA Smallpox Vaccine Programme With Publication Of Phase I Trial Results
October 19, 2005
 · 
1 min read
Drug Development
Croup Vaccine Safe In Early Study
October 19, 2005
 · 
1 min read
Drug Development
New SARS Vaccine Works in Mice, Human Trials Near
October 19, 2005
 · 
1 min read
Drug Development
Novel c-Myc Oncogene Inhibitor To Advance To Clinical Trials
October 19, 2005
 · 
2 min read
Drug Development
Basilea Has Successful Debut With $161M IPO In Switzerland
October 19, 2005
 · 
1 min read
Drug Development
Human Trials Of New Anti-HIV Gels Announced
October 19, 2005
 · 
1 min read
Drug Development
Torcetrapib Improves Ratio Of HDL To LDL Cholesterol
October 19, 2005
 · 
2 min read
Load More
PRESS RELEASES
Press Releases
Oorja Bio Unveils Clinical Data for ORJ-001, a First-in-Class Therapeutic Targeting Alveolar Epithelial Type 2 (AEC2) Cells for Treatment of Idiopathic Pulmonary Fibrosis (IPF)
May 19, 2026
 · 
6 min read
Press Releases
Myosin Therapeutics Initiates Phase 1/2 STAR-GBM Trial of MT-125 Targeting Non-muscle Myosin II in Newly Diagnosed Glioblastoma
May 19, 2026
 · 
2 min read
Press Releases
Mabylon Reports Positive Phase Ia Results in MY006 Peanut Allergy Trial and Initiates Phase Ib Patient Part of the Study; Advances Tree Pollen Allergy Program MY010 toward Clinical Development
May 19, 2026
 · 
1 min read
Press Releases
MEKanistic Therapeutics Announces FDA Clearance of IND for MTX-531, Enabling Phase 1 Trial in Advanced Solid Tumors
May 19, 2026
 · 
2 min read
Press Releases
Propanc Biopharma Engages European CDMO for GMP Production of PRP for Phase 1b, FIH Study in 30 – 40 Advanced Cancer Patients
May 19, 2026
 · 
4 min read
Press Releases
Vertero Advances into Phase 1b Study with VT-5006 for the Treatment of Parkinson’s Disease
May 19, 2026
 · 
4 min read
Press Releases
Vanqua Bio to Present Positive Biomarker Data from Ongoing Phase 1b Study at Upcoming Medical Conferences
May 19, 2026
 · 
2 min read
Press Releases
Mestag Therapeutics Announces the First Patient Dosed with MST-0312 in the Phase I STARLYS Trial
May 19, 2026
 · 
5 min read
Press Releases
/C O R R E C T I O N -- Skyhawk Therapeutics/
May 18, 2026
 · 
2 min read
Press Releases
Dragonfly Therapeutics Announces Encouraging Early Results from the Phase 1 for DF5112, its CCR6-Targeting Molecule
May 18, 2026
 · 
1 min read
Press Releases
Vast Therapeutics Presents Late-Breaking Phase 1 Data for Inhaled Therapy ALX1 at ATS 2026
May 18, 2026
 · 
2 min read
Press Releases
Bambusa Therapeutics Presents Positive Preliminary Phase 1 BBT002 Data at American Thoracic Society 2026 (ATS 2026) International Conference and Announces First Patient Dosed in Phase 1b/2a CRSwNP Trial
May 18, 2026
 · 
6 min read
Press Releases
Triveni Bio Doses First Healthy Volunteers with Next-Generation Bispecific Antibody TRIV-573 Targeting Kallikreins 5 & 7 and Interleukin 13 in Phase 1 Clinical Trial
May 18, 2026
 · 
3 min read
Press Releases
Earendil Labs Announces First Cohort Dosed in Phase I Study of Novel Biparatopic Antibody Targeting Thymic Stromal Lymphopoietin (TSLP)
May 18, 2026
 · 
2 min read
Press Releases
SEED Therapeutics to Present Phase 1 Trial Design for ST-01156, a First-in-Human Oral RBM39 Molecular Glue Degrader, at 2026 ASCO Annual Meeting
May 18, 2026
 · 
3 min read
Press Releases
Design Therapeutics Announces Four-Week IV Data from the RESTORE-FA Trial of DT-216P2 Demonstrating Clinical Improvements and Comprehensive Biomarker Activity in Friedreich Ataxia
May 18, 2026
 · 
8 min read
Press Releases
Context Therapeutics Enters into License Agreement Amendment with BioAtla for CT-202
May 18, 2026
 · 
4 min read
Press Releases
Prokarium Reports Positive Interim Data from Phase 1/1b PARADIGM-1 trial of ZH9 in NMIBC patients, Demonstrating Excellent Safety and Encouraging Early Efficacy
May 18, 2026
 · 
2 min read
Press Releases
Design Therapeutics to Host Investor Webcast to Review Data from RESTORE-FA Trial of DT-216P2 for Friedreich’s Ataxia on Monday, May 18, 2026
May 17, 2026
 · 
1 min read
Press Releases
Agenus Announces Publication of Phase 1b Botensilimab and Balstilimab Data in Post-Immunotherapy Hepatocellular Carcinoma in Liver Cancer
May 17, 2026
 · 
9 min read
Load More